Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
The Journal of Dermatological Treatment|March 31, 2023
Long-term management of pediatric psoriasis with ixekizumab: a case reportDiego Orsini, Luciano Ibba, Alessandra Narcisi, et al.Dermatology and Therapy|April 23, 2022
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective StudyLuigi Gargiulo, Giulia Pavia, Mario Valenti, et al.Dermatologic Therapy|December 8, 2021
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective studyGiulia Pavia, Luigi Gargiulo, Andrea Cortese, et al.The Journal of Dermatological Treatment|March 11, 2021
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patientsAlessandra Narcisi, Mario Valenti, Clara De Simone, et al.The Journal of Dermatological Treatment|November 7, 2024
Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective studyLuciano Ibba, Sara Di Giulio, Luigi Gargiulo, et al.Journal of Clinical Medicine|May 14, 2025
Real-World Effectiveness and Safety of Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective StudyLuciano Ibba, Costanza Falcidia, Sara Di Giulio, et al.Journal of Clinical Medicine|October 29, 2025
Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center StudyMatteo Bianco, Francesco D'Oria, Gioele Ghezzi, et al.The Journal of Investigative Dermatology|July 3, 2024
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment OptionsCarlo Alberto Maronese, Mario Valenti, Chiara Moltrasio, et al.Melanoma Research|October 8, 2021
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapyLuigi Gargiulo, Maria Chiara Tronconi, Maria S Grimaudo, et al.Journal of Clinical Medicine|September 27, 2025
Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter StudySara Di Giulio, Costanza Falcidia, Giulio Foggi, et al.Pageof 8